Rx Marketplace Quarterly: Q4 2019 Pharmaceutical and Life Sciences

Start adding items to your reading lists:
Save this item to:
This item has been saved to your reading list.

December 18, 2019

In this issue of Rx Marketplace you will find an overview of recent capital market activity, Swiss tax reform, the latest developments on the medical device excise tax, SEC comment letter trends, and annual reporting considerations.

In our spotlight section, we feature an overview of PwC’s Health Research Institute’s report, Top health industry issues of 2020: Will digital start to pay off?

Updated Health Industries SEC comment letter trends

Our analysis of SEC comment letters identifies the frequency of topical areas addressed by the SEC staff and how their focus has evolved over time. We have updated the top ten rankings and topics to include those comment letters issued to Health industries companies through September 30, 2019.

Spotlight on PwC's Health Research Institute (HRI)

HRI recently launched, Top health industry issues of 2020: Will digital start to pay off? After surveying over 3,500 American consumers, 300 provider executives, 100 payer executives, and 100 executives from PLS companies, it is clear that the top issue in 2020 will be evaluating how investments in technology and digital transformation will impact healthcare consumers. As a result, it will become increasingly important for healthcare companies to make the most of their technology, data, and digital investments to improve delivery and lower costs.

Contact us

Laura Robinette

US Pharmaceutical & Life Sciences Assurance Leader, PwC US

Follow us